Видео с ютуба Value-Added-Medicines

Medicines for Europe - Value Added Medicines

Global Generic, Biosimilar and Value Added Medicines Conference (2018)

Why should healthcare systems consider value added medicines? Marc-Alexander Mahl,

What is the importance of Value Added Medicines in the digital space? Sarah Neville, Financial Times

What are the challenges faced by Value Added Medicines - Arun Narayan, VAM WG Group chair

Promoting value-added medicines and renovating old medicines smartly

Why are value added medicines important for health systems? Ann Beliën

Can value added medicines make a difference to patients & health systems? Mark Milton Edwards

Importance of value added medicines to health systems - Albert Werthiemer

Delivering Benefits for Patients and health systems through value added medicines

Value Added Medicines: Rethink, reinvent, optimise medicines - European Parliament event

How can we improve access to value added medicines? Florian Turk, Global Head Commercial Sandoz

Physician perspectives on value added medicines - Jean Bousquet

The future of value added medicines - Arun Narayan

Patient voice, healthcare agenda and value added medicines - Donna Walsh, EFNA Executive Director

How can Value Added Medicines respond to patients' unmet needs - Arun Narayan, VAM WG Group chair

Pharmapack 2020 - Conference - Digital Value Added Medicines

Can value added medicines deliver for patients? Jeanette Andersen, Lupus Europe

Value added medicines award 2019: Prof Jean Bousquet, MASK digital anamorphosis (winner)

Patient perspectives on value added medicines - Susanna Palkonen